Click here to view the End TB 2017 Abstract Book.
Presentation Slides - February 22, 2017
The Impact of Laboratory Advances on Clinical and Public Health Practice
Whole Genome Sequencing for the Diagnosis of Drug Resistance: are we there yet?
Dr. Maha Farhat, Harvard University, Boston, MA, USA
Understanding Transmission in Low-Incidence Settings with Whole Genome Sequencing
Dr. Jennifer Gardy, BC Centre for Disease Control, Vancouver, BC, Canada
WHO/ATS TB Treatment Guidelines
TB Laboratory Diagnostics LPA FLD/SLD (video-conference)
Dr. Christopher Gilpin, World Health Organization, Geneva, Switzerland
ATS/CDC/IDSA Treatment of TB Guidelines
Dr. Payam Nahid, University of California San Francisco, San Francisco, CA, USA
Ethics: Ethical Issues in the Implementation of the WHO's End TB Strategy
Dr. Diego Silva, Simon Fraser University, Burnaby, BC, Canada
Presentation Slides - February 23, 2017
Stop TB Meeting: Global and Regional Challenges in TB Elimination
Global Impact of the Short-Course TB Regimen
Dr. Charles Daley, National Jewish Health, Denver, CO, USA
Advocacy for Drug Access
Mr. Suraj Madoori, Treatment Action Group, New York, NY, USA
The 3P Project: Accelerating Innovation and Access to TB Medications
Dr. Grania Brigden, The Union, Paris, France
Nursing-Sponsored Session: TB Elimination through Collaborative Partnerships
Cultural Proficiency - Fundamental Concepts
Ms. Kay Wallis, Curry International Tuberculosis Center, Oakland, CA, USA
Orientation to SNTC Country Specific Guides for Health Professionals Working with Foreign-born Clients
Dr. Connie Haley, Southeastern National Tuberculosis Center, Gainesville, FL, USA
New Technologies and TB – TB ECHO Projects
Ms. Diana Fortune, New Mexico Department of Health, Santa Fe, New Mexico, USA
The George Comstock Lecture
Putting Quality on the Tuberculosis Agenda
Dr. Madhukar Pai, McGill University, Montreal, QC, Canada
Presentation Slides - February 24, 2017
TB in Remote Northern and Indigenous Communities
TB in the Global North - Caring for Those in Remote and Indigenous Communities
Dr. Lisa V. Adams, Dartmouth College, Hanover, NH, USA
Social Determinants of Health in Remote Communities
Dr. Malcolm King, Simon Fraser University, Burnaby, BC
Virtual Clinic Models for Managing Remote Care
Dr. Richard Long, University of Alberta, Edmonton, AB, Canada
Implementation of GeneXpert Testing in Remote Communities: From A to Z
Dr. Gonzalo Alvarez, University of Ottawa, Ottawa, ON, Canada
TB Immigration and Migration
Role of Expanded LTBI Testing and Treatment in TB Elimination Efforts
Dr. Philip LoBue, Centers for Disease Control and Prevention, Atlanta, GA, USA
Presentation Slides - February 25, 2017
TB and New Technologies
The WHO Digital Health Agenda for the End TB Strategy
Dr. Dennis Falzon, World Health Organization, Geneva, Switzerland
VDOT in the UK: Results of a Randomized Control Trial
Dr. Alistair Story, University College London, London, UK
Use of PCR-based Diagnostics in the United States
Dr. Neha Shah, Centers for Disease Control and Prevention, Richmond, CA, USA
Subclinical TB: Immunology and Host Response
Developing an RNA Signature Predictive of TB Progression
Dr. Dan Zak, Center for Infectious Disease Research, Seattle, WA, USA
What is Persistence?
Dr. David Sherman, Center for Infectious Disease Research, Seattle, WA, USA